Compass Therapeutics, Inc.
CMPXNasdaqCIK 1738021HealthcareFiscal year ends Dec 31
Reports and events: 112 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2212:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-006162 |
| 2026-08-0612:00 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001171843-26-005295 |
| 2026-08-0611:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005292 |
| 2026-07-0121:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-004428 |
| 2026-06-2321:45 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001171843-26-004224 |
| 2026-06-1120:00 ET | 8-K | 5.07 Shareholder vote results | 0001171843-26-004068 |
| 2026-05-0512:01 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001171843-26-003006 |
| 2026-05-0511:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-003005 |
| 2026-04-2912:08 ET | DEF 14A | Proxy statementPeriod 2026-06-10 | 0001140361-26-017649 |
| 2026-04-2711:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-002720 |
| 2026-03-0512:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001171843-26-001337 |
| 2026-03-0512:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-001336 |
| 2026-01-0613:00 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-000083 |
| 2025-11-0512:30 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001171843-25-007005 |
| 2025-11-0512:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-007004 |
| 2025-08-1822:35 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-109869 |
| 2025-08-1521:28 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-25-000785 |
| 2025-08-1321:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-179958 |
| 2025-08-1111:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001171843-25-005261 |
| 2025-08-1111:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-005260 |
| 2025-06-1220:45 ET | 8-K | 5.07 Shareholder vote results | 0001171843-25-003868 |
| 2025-05-0812:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001171843-25-002953 |
| 2025-05-0812:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-002952 |
| 2025-04-2912:30 ET | DEF 14A | Proxy statementPeriod 2025-06-11 | 0001171843-25-002573 |
| 2025-04-1123:21 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-25-000383 |
| 2025-04-0111:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-001900 |
| 2025-02-2713:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001171843-25-001106 |
| 2025-02-2713:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-001105 |
| 2025-01-0813:00 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-000116 |
| 2024-12-1013:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-006847 |
| 2024-11-1213:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001171843-24-006248 |
| 2024-11-1213:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-006247 |
| 2024-08-1212:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001171843-24-004670 |
| 2024-08-1212:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-004669 |
| 2024-06-1712:32 ET | 8-K | 5.07 Shareholder vote results | 0001171843-24-003463 |
| 2024-05-2820:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-003129 |
| 2024-05-1312:01 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001171843-24-002785 |
| 2024-05-1312:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-002784 |
| 2024-04-2912:00 ET | DEF 14A | Proxy statementPeriod 2024-06-13 | 0001140361-24-022700 |
| 2024-04-2512:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-002220 |
| 2024-03-2220:59 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-24-000303 |
| 2024-03-2113:00 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001171843-24-001516 |
| 2024-03-2113:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-001515 |
| 2024-01-0922:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001171843-24-000164 |
| 2024-01-0513:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-000082 |
| 2023-11-0912:30 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001171843-23-006912 |
| 2023-11-0912:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-006911 |
| 2023-08-0312:01 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001171843-23-004947 |
| 2023-08-0312:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-004946 |
| 2023-06-1515:15 ET | 8-K | 5.07 Shareholder vote results | 0001171843-23-003943 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.